Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $885 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald has reiterated its Overweight rating on Eli Lilly and Co (NYSE: LLY) and maintained a price target of $885.
June 20, 2024 | 1:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated its Overweight rating on Eli Lilly and Co (NYSE: LLY) and maintained a price target of $885.
The reiteration of an Overweight rating and a high price target of $885 by Cantor Fitzgerald is a positive signal for investors, suggesting confidence in Eli Lilly's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100